A research team, affiliated with UNIST has developed nanoparticles that effectively treat acute myeloid leukemia (AML), ...

AvenCell Therapeutics on Tuesday said it collected $112 million to continue clinical studies of two experimental acute ...

"The first thing in my head was, 'Oh my gosh, I don't get to go to Taylor Swift,'" Hannah Everson said of learning her cancer ...

A leukemia diagnosis can feel like a sudden storm, upending lives and leaving patients and families grappling with ...

Harvey Weinstein has been diagnosed with bone cancer, a source close to the incarcerated producer tells CNN. Weinstein’s ...

Raymond F. Altman, a three-time All American who left a legacy in the record books at College Park, died Oct. 12 at Gilchrist ...

Chronic myeloid leukemia (CML) is a rare type of cancer that forms in the bone marrow before spilling into the blood. It is a ...

A 24-year-old Houston Texans draft pick and wide receiver was identified as a potential trade candidate for the Pittsburgh Steelers.

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today ...

While there have been exciting advancements in the treatment of B-cell acute lymphoblastic leukemia over the course of the past decade, the treatment of older adults remains a challenge.

AvenCell Therapeutics has secured $112 million in series B funds as the Novo Holdings-backed biotech seeks clinical proof ...